MorphoSys AG buy BastiBBC
Summary
This prediction ended on 04.10.12 with a price of €26.00. With a performance of 43.13% the BUY prediction by BastiBBC was a big success. BastiBBC has 50% into this predictionMorphoSys is a German biopharmaceutical company that develops innovative therapies for the treatment of cancer, autoimmune diseases, and other serious illnesses. The company specializes in developing monoclonal antibodies, which are highly specific and targeted therapies that recognize and bind to specific cancer cells or disease-causing proteins in the body. MorphoSys has a diverse pipeline of products in various stages of development, including several drugs that have shown promising results in clinical trials. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of over $4 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| MorphoSys AG | 2.690% | 2.690% | 225.695% | -9.313% |
| iShares Core DAX® | 0.476% | -0.039% | 13.342% | 17.330% |
| iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% | 50.534% |
| iShares Nikkei 225® | 1.300% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 0.829% | 0.193% | 29.756% | 43.432% |
Comments by BastiBBC for this prediction
In the thread Morphosys AG diskutieren
Kaufen
Morphosys kaufen. Zwar ein bisschen spät, aber besser als nie. Das Kursziel für die nächsten sechs Monate sehe ich bei ca. 26 Euro.